| Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods | 2020/05/01 | English | 1,386 |
| HIF-1α pathway: role, regulation and intervention for cancer therapy | 2015/09/01 | English | 1,194 |
| Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges | 2016/07/01 | English | 853 |
| Insoluble drug delivery strategies: review of recent advances and business prospects | 2015/09/01 | English | 842 |
| Cancer metastases: challenges and opportunities | 2015/09/01 | English | 584 |
| Recent progress in drug delivery | 2019/11/01 | English | 481 |
| Mesoporous silica nanoparticles for drug and gene delivery | 2018/03/01 | English | 450 |
| Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites | 2020/07/01 | English | 415 |
| An updated overview on the development of new photosensitizers for anticancer photodynamic therapy | 2018/03/01 | English | 382 |
| Fundamental aspects of solid dispersion technology for poorly soluble drugs | 2014/02/01 | English | 379 |
| Targeting calcium signaling in cancer therapy | 2017/01/01 | English | 366 |
| Nonionic surfactant vesicular systems for effective drug delivery—an overview | 2011/12/01 | English | 357 |
| Adapting liposomes for oral drug delivery | 2019/01/01 | English | 352 |
| Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application | 2019/07/01 | English | 348 |
| The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb | 2015/07/01 | English | 342 |
| Smart polymers for the controlled delivery of drugs – a concise overview | 2014/04/01 | English | 339 |
| Mechanisms of resistance to EGFR tyrosine kinase inhibitors | 2015/09/01 | English | 331 |
| Why 90% of clinical drug development fails and how to improve it? | 2022/07/01 | English | 320 |
| Progress and perspectives on targeting nanoparticles for brain drug delivery | 2016/07/01 | English | 312 |
| Oral lipid-based drug delivery systems – an overview | 2013/12/01 | English | 295 |
| Human carboxylesterases: a comprehensive review | 2018/09/01 | English | 292 |
| Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment | 2018/01/01 | English | 269 |
| Gasdermin D in pyroptosis | 2021/09/01 | English | 266 |
| Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy | 2018/07/01 | English | 252 |
| Biomacromolecules as carriers in drug delivery and tissue engineering | 2018/01/01 | English | 251 |
| Bile acid nuclear receptor FXR and digestive system diseases | 2015/03/01 | English | 245 |
| Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials | 2016/07/01 | English | 243 |
| Long non-coding RNAs: From disease code to drug role | 2021/02/01 | English | 240 |
| PBPK modeling and simulation in drug research and development | 2016/09/01 | English | 228 |
| Targeting the untargetable KRAS in cancer therapy | 2019/09/01 | English | 224 |